Sakar Healthcare Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Sakar Healthcare Limited generated cash of $244,669,000, which is less than the previous year. Cash used in financing activities reached the amount of $274,447,000 last year. Net change in cash is therefore $3,723,000.
Cash Flow
| 2016 | 918 | -359 | -629 |
|---|---|---|---|
| 2018 | 52.64M | -82.77M | -129.93M |
| 2020 | 101.24M | -136.76M | 34.80M |
| 2021 | 145.76M | -468.33M | 320.33M |
| 2023 | 353.14M | -743.76M | 410.96M |
| 2024 | 244.66M | -515.39M | 274.44M |
SAKAR.NS Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 933K | 299K | 3.05M | 3.66M | 4.51M | 93 |
Operating activities | ||||||
Net income | 116.70M | 168.76M | 132.32M | 122.26M | 61.09M | 22.17M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 180.50M | 149.86M | 80.58M | 70.79M | 44.09M | 273 |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 11.48M | -79.08M | -41.43M | 12.69M | 54.74M | 9.71M |
Inventories | 0 | -12.14M | -47.63M | -40.77M | -30.26M | -29 |
Accounts payable | 0 | -44.16M | 25.90M | 11.19M | 13.03M | 30.14M |
Cash generated by operating activities | 244.66M | 353.14M | 145.76M | 101.24M | 52.64M | 918 |
Investing activities | ||||||
Purchases Of Investments | 0 | -40.15M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -595.60M | -821.95M | -355.45M | -136.66M | -88.09M | -379 |
Acquisitions Net | 0 | 40.15M | 0 | -100K | 0 | 0 |
Cash generated by investing activities | -515.39M | -743.76M | -468.33M | -136.76M | -82.77M | -359 |
Financing activities | ||||||
Common Stock Issued | 774.19M | 333.5M | 78.84M | 43.76K | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | -43.44M | 0 |
Repayments of term debt | -432.73M | 132.20M | -254.83M | 52.09M | -60.63M | -336 |
Cash used in financing activities | 274.44M | 410.96M | 320.33M | 34.80M | -129.93M | -629 |
Net Change In Cash | 3.72M | 634K | -2.23M | -708.49K | -160.05M | -70 |
Cash at end of period | 4.65M | 933K | 824.64K | 2.95M | -155.53M | 22 |
| Data source | Data source | Data source | Data source | Data source | Data source |